Informed consent for medical treatment and research: A review

被引:94
作者
del Carmen, MG
Joffe, S
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gynecol Oncol,Vincent Obstet & Gynecol, Boston, MA USA
[2] Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol,Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
informed consent; treatment; autonomy; ethics; law;
D O I
10.1634/theoncologist.10-8-636
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The practice of informed consent has historical roots in various disciplines, including medicine, moral philosophy, and the law. It is closely tied to philosophical notions of respect for persons and respect for individual autonomy. Consent to treatment is rooted in case law. Consent to research, in contrast, has its basis in ethical codes, statutes, and administrative regulations, with the courts playing a lesser role. In this article, we define the elements of informed consent in the treatment setting, outline its ethical and legal foundations, and explore some of its limitations. We contend that informed consent plays a critical role in clinical medicine but that other models of decision making deserve consideration under particular circumstances. We also delineate the current federal regulatory schemes guiding human subject research in the U.S., highlight how consent to research differs from consent to treatment, and explore the difficulties that arise in research involving cancer patients and certain vulnerable populations.
引用
收藏
页码:636 / 641
页数:6
相关论文
共 31 条
[21]   Communication of randomization in childhood leukemia trials [J].
Kodish, E ;
Eder, M ;
Noll, RB ;
Ruccione, K ;
Lange, B ;
Angiolillo, A ;
Pentz, R ;
Zyzanski, S ;
Siminoff, LA ;
Drotar, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (04) :470-475
[22]  
Lederer SE., 1995, SUBJECTED SCI HUMAN, P1
[23]  
MEISEL A, 1977, AM J PSYCHIAT, V134, P285
[24]  
National Cancer Institute, 1999, GUID REP ADV DRUG RE, P1
[25]  
*OFF PROT RES RISK, 1993, I REV BOARD GUID PRO, P1
[26]   Protective truthfulness: the Chinese way of safeguarding patients in informed treatment decisions [J].
Pang, MCS .
JOURNAL OF MEDICAL ETHICS, 1999, 25 (03) :247-253
[27]  
REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85
[28]  
Schneider Carl E., 1998, PRACTICE AUTONOMY, P1
[29]  
U.S. Department of Health and Human Services, 1983, FED REGISTER, V48, P9818
[30]  
*US NAT COMM PROT, 1978, BELM REP ETH PRINC G, P1